Literature DB >> 7928409

Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse.

A Signore1, E Procaccini, A M Toscano, E Ferretti, A J Williams, P E Beales, P Cugini, P Pozzilli.   

Abstract

Non-obese diabetic (NOD) mice spontaneously develop an autoimmune diabetes with higher incidence in females than in males. In order to elucidate possible factors involved in the different incidence of diabetes between male and female mice, we studied the progression of pancreatic beta-cell loss in relation to mononuclear cell infiltration of the pancreas (insulitis). We examined the pancreas of 76 NOD mice (39 males and 37 females) of different ages. The beta-cell content was assessed by immunoperoxidase staining of sections with an anti-insulin serum and the severity of insulitis was determined by haematoxylin staining of the same sections. A semi-quantitative criterion was used to grade both parameters. The results showed that females have a faster loss of beta-cell mass, which progressively decreases with the increase of severity of insulitis. In males, a medium to severe degree of insulitis is required before initial loss of beta cells occurs. Under the age of 10 weeks there was a significantly lower content of beta cells in females than males (2.84 +/- 0.03 vs 2.67 +/- 0.07; P = 0.02). Since we never observed a significant difference in the degree of mononuclear cell infiltration in age-matched males and females, these data support the hypothesis of weaker beta-cell resistance to immunological attack in female mice. Thus beta-cell sensitivity, in addition to immunological activity, is an important factor in the pathogenesis of insulin dependent diabetes.

Entities:  

Mesh:

Year:  1994        PMID: 7928409     DOI: 10.1007/bf00315913

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  26 in total

1.  Parallelism test on microcomputers for statistically comparing regression lines of bivariate data sets.

Authors:  P Cugini; G Leone; M Sepe; L Di Palma
Journal:  Comput Methods Programs Biomed       Date:  1990-10       Impact factor: 5.428

2.  Binding of 3H-progesterone by isolated rat islets of Langerhans.

Authors:  I C Green; S L Howell; S El Seifi; D Perrin
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

3.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

4.  Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  O Pontesilli; P Carotenuto; L S Gazda; P F Pratt; S J Prowse
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.

Authors:  E Strandell; D L Eizirik; S Sandler
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

7.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

8.  Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation.

Authors:  A Rabinovitch; W L Suarez; P D Thomas; K Strynadka; I Simpson
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 9.  Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Authors:  E F Lampeter; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

10.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
View more
  9 in total

Review 1.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.

Authors:  C J Fox; A D Paterson; S M Mortin-Toth; J S Danska
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

3.  Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.

Authors:  H Rothe; N A Jenkins; N G Copeland; H Kolb
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

4.  Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier.

Authors:  Minhyung Lee; Jae Joon Koh; Sang-Oh Han; Kyung Soo Ko; Sung Wan Ki
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

5.  In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.

Authors:  Daniel J Moore; Jozef Zienkiewicz; Peggy L Kendall; Danya Liu; Xueyan Liu; Ruth Ann Veach; Robert D Collins; Jacek Hawiger
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

6.  Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes.

Authors:  Wan Seok Joo; Ji Hoon Jeong; Kihoon Nam; Katherine S Blevins; Mohamed E Salama; Sung Wan Kim
Journal:  J Control Release       Date:  2012-08-14       Impact factor: 9.776

7.  Exendin-4 modulates diabetes onset in nonobese diabetic mice.

Authors:  Irene Hadjiyanni; Laurie L Baggio; Philippe Poussier; Daniel J Drucker
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

8.  Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice.

Authors:  E S Yolcu; H Zhao; H Shirwan
Journal:  Transplant Proc       Date:  2013-06       Impact factor: 1.066

9.  Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes.

Authors:  Johanna Bodin; Else-Carin Groeng; Monica Andreassen; Hubert Dirven; Unni Cecilie Nygaard
Journal:  Toxicol Rep       Date:  2016-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.